1,090 MXN
85
8.46%
Last update Dec 4, 1:48 PM CST
Market closed
Day range
1,063.88000
1,090
Previous close
1,005
Open
1,063.88000
Access this stock data via API
Subscribe
Crispr Therapeutics AG
1,090.00
85
8.46%

Statistics

Valuation metrics
Market cap
0
Enterprise value
1.84T
Trailing P/E (ttm)
13.93
Forward P/E
PEG ratio
Price/Sales (ttm)
Price/Book (mrq)
2.96
Enterprise Value/Revenue
2.67K
Enterprise Value/EBITDA
-222.37
Overview
Shares outstanding
Float
94.80M
Shares short
% Held by insiders
1.61%
% Held by institutions
77.94%
Average volume (10 days)
441
Average volume (90 days)
263
Price summary
52-Week low
727.07
52-Week high
1.38K
52-Week change
27.25 3.7%
Beta
1.73
50-Day moving average
1.11K
200-Day moving average
1.03K
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Dec 31, 2024
Profitability
Profit margin
0
Operating margin
-14,854.78%
Operational effectiveness
Return on assets
-13.28%
Return on equity
-25.33%
Income statement
Revenue (ttm)
690.61M
Revenue per share (ttm)
0.44
Quarterly revenue growth (yoy)
47.70%
Gross profit (ttm)
-7.76B
EBITDA
-8.28B
Net income to common (ttm)
-8.80B
Diluted EPS (ttm)
78.24
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
34.51B
Total cash per share (mrq)
20.10
Total debt (mrq)
3.80B
Total Debt/Equity (mrq)
11.01
Current ratio (mrq)
1,621.70%
Book value per share (mrq)
367.99
Cash flow
Cash flow statement
-5.45B
Levered free cash flow (LFCF)
-3.73B
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 30 minutes

23:59
00:00
08:30
15:00
23:59

Trading Hours (Monday - Friday):

Main market
08:30 - 15:00
All times are displayed in the America/Swift_Current timezone (CST, UTC-06:00).